Pulmonary Clinical Pharmacy Practice

Mitenko PA Ogilvie RI . Rational intravenous doses of theophylline. N Engl J Med 1973;289:600–3.

Masseli R Casal GL Ellis EF . Pharmacologic effects of intravenously administered aminophylline in asthmatic children. J Pediatr 1970;76:777–82.

Hendeles L Bighley L Richardson RH Hepler CD Carmichael J . Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 1977;11:12–7.

Kelly HW Lovato C . Antibiotic use in cystic fibrosis. Drug Intell Clin Pharm 1984;18:772–83.

Weinberger MM Bronsky EA . Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children. J Pediatr 1974;84:421–7.

Kelly HW Murphy S Hadley WM Skipper B . Correlation of serum and saliva theophylline levels using a sustained release theophylline preparation. Am J Dis Child 1981;135:137–9.

Vaughan LM Milavetz G Weinberger MM Smith GD Merrick JG . Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children. Drug Intell Clin Pharm 1988;22:684–7.

National Institutes of Health, NHLBI, National Asthma Education and Prevention Program, Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. NIH publication number 91–3642. Washington, DC: National Institutes of Health, 1991.

Kelly HW Murphy S . Should anticholinergics be used in acute, severe asthma? DICP Ann Pharmacother 1990;24:409–16.

Reed MT Kelly HW . Sympathomimetics for acute, severe asthma: should only beta-2-selective agonists be used? DICP Ann Pharmacother 1990;24:868–73.

Kelly HW Murphy S . Corticosteroids for acute, severe asthma. DICP Ann Pharmacother 1991;25:72–9.

Kelly HW Murphy S . Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother 1992;26:81–91.

Kharitonov SA Barnes PJ . Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693–722.

Palmer LJ Silverman ES Weiss ST Drazen JM . Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002;165:861–6.